diclofenac sodium- diclofenac sodium solution
actavis pharma, inc. - diclofenac sodium (unii: qtg126297q) (diclofenac - unii:144o8ql0l1) - diclofenac sodium 16.05 mg in 1 ml - diclofenac sodium topical solution is indicated for the treatment of signs and symptoms of osteoarthritis of the knee(s) (1). diclofenac sodium is contraindicated in the following patients: - known hypersensitivity (e.g., anaphylactic reactions and serious skin reactions) to diclofenac or any components of the drug product. [see warnings and precautions ( 5.7 , 5.9 )] . - history of asthma, urticaria, or other allergic-type reactions after taking aspirin or other nsaids. severe, sometimes fatal, anaphylactic reactions to nsaids have been reported in such patients [see warnings and precautions ( 5.7 , 5.8 )] . - in the setting of coronary artery bypass graft (cabg) surgery [see warnings and precautions (5.1) ] . pregnancy category c prior to 30 weeks gestation; category d starting 30 weeks gestation risk summary use of nsaids, including diclofenac sodium, during the third trimester of pregnancy increases the risk of premature closure of the fetal ductus arteriosus. avoid use of nsaids, including diclofenac
caspofungin mylan 50mg powder for concentrate for solution for infusion
mylan s.a.s. 117 allee des parcs, 69800 saint priest, france - caspofungin acetate - powder for concentrate for solution for infusion - caspofungin acetate 50 milligram(s) - antimycotics for systemic use
caspofungin mylan 70mg powder for concentrate for solution for infusion
mylan s.a.s. 117 allee des parcs, 69800 saint priest, france - caspofungin acetate - powder for concentrate for solution for infusion - caspofungin acetate 70 milligram(s) - antimycotics for systemic use
juliana 0.02mg/3mg film-coated tablets
mithra pharmaceuticals s.a rue saint-georges 5, 4000, liege, belgium - ethinylestradiol, drospirenone - film-coated tablet - ethinylestradiol 0.02 mg drospirenone 3 mg - sex hormones and modulators of the genital system
juliana 28 0.02mg/3mg film-coated tablets
mithra pharmaceuticals s.a rue saint-georges 5, 4000, liege, belgium - ethinylestradiol, drospirenone - film-coated tablet - ethinylestradiol 0.2 mg drospirenone 3 mg - sex hormones and modulators of the genital system
caspofungin mylan pdr/conc/soln for infus 50mg
mylan s.a.s. 117 allee des parcs, 69800 saint priest, france - caspofungin acetate - powder for concentrate for solution for infusion - caspofungin acetate - antimycotics for systemic use
caspofungin mylan pdr/conc/soln for infus 70mg
mylan s.a.s. 117 allee des parcs, 69800 saint priest, france - caspofungin acetate - powder for concentrate for solution for infusion - caspofungin acetate 75.6 mg - antimycotics for systemic use
mitoxantrone mylan concentrate for soln for inf 2mg/ml
mylan s.a.s. 117 allee des parcs, 69800 saint priest, france - mitoxantrone - concentrate for solution for infusion - mitoxantrone 2 mg/ml - antineoplastic agents
triasyn 2.5/2.5 tablet blister pack
sanofi-aventis australia pty ltd - felodipine, quantity: 2.5 mg; ramipril, quantity: 2.5 mg - tablet, modified release - excipient ingredients: aluminium sodium silicate; hyprolose; iron oxide yellow; pregelatinised maize starch; lactose; microcrystalline cellulose; propyl gallate; iron oxide red; hypromellose; sodium stearylfumarate; titanium dioxide; macrogol 6000; hard paraffin; peg-40 hydrogenated castor oil - for the treatment of mild to moderate hypertension. this combination should not be used to commence therapy.
triasyn 5.0/5.0 tablet blister pack
sanofi-aventis australia pty ltd - felodipine, quantity: 5 mg; ramipril, quantity: 5 mg - tablet, modified release - excipient ingredients: macrogol 6000; microcrystalline cellulose; aluminium sodium silicate; hard paraffin; lactose; sodium stearylfumarate; propyl gallate; pregelatinised maize starch; hyprolose; peg-40 hydrogenated castor oil; iron oxide yellow; hypromellose; iron oxide red; titanium dioxide - for the treatment of mild to moderate hypertension. this combination should not be used to commence therapy.